Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF)

• Status: Completed
• Trial end date: 2005-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effects of spironolactone and furosemide on insulin resistance in patients with chronic heart failure.

• Phase: Phase 4

Details

• Lead Sponsor: Tottori University Hospital
• Treatments: Furosemide; Insulin; Spironolactone

Criteria

Inclusion Criteria:

• chronic stable heart failure

Exclusion Criteria:

• renal dysfunction or under treatment with antidiabetic agents